<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02066922</url>
  </required_header>
  <id_info>
    <org_study_id>C-12-057</org_study_id>
    <nct_id>NCT02066922</nct_id>
  </id_info>
  <brief_title>A Comparative Study of Two Daily Disposable Contact Lenses in Higher Myopia Subjects</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the change from baseline in central corneal curvature
      at one week, between 2 silicone hydrogel lenses, in higher myopic subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants were expected to attend 4 office visits. Visit 1 was the Screening/Enrollment
      visit. At Visit 2 (Baseline Visit), participants were randomized and the study lenses were
      trial fit. At Visit 3 (Dispense Visit), participants received study lenses for approximately
      1 week of wear. Visit 4 was the Exit visit. Expected duration of participation in the study
      was 3 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Average Central Corneal Curvature From Dispense at Week 1</measure>
    <time_frame>Dispense (Day 1 of lens wear), Week 1 (Day 8 of lens wear)</time_frame>
    <description>Corneal curvature (horizontal and vertical keratometry values on the same eye) was measured using a calibrated keratometer prior to study lens dispense (Day 1) and approximately 15 minutes after study lens removal following 8 hours of wear (Week 1). Minus values in change-from-baseline indicate corneal flattening.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Eyes With Change of &gt;1.00 Diopter (D) in Spherical Equivalent of Subjective Refraction From Baseline at Week 1</measure>
    <time_frame>Baseline, Week 1 (Day 8 of lens wear)</time_frame>
    <description>Subjective manifest refraction was assessed using a phoropter or trial frame set with the subject's current prescription at Baseline (Visit 2) after a 2-day washout period and approximately 15 minutes after study lens removal following 8 hours of wear (Week 1). Spectacle over-refraction, if required, was performed. Higher myopia is indicated by larger negative values in manifest refraction.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Refractive Error</condition>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>DAILIES TOTAL1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Delefilcon A contact lens randomly assigned to one eye, with narafilcon A contact lens in the fellow eye for contralateral wear. Both products worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week, with spectacles worn over contact lenses if needed to provide acceptable vision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRUEYE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Narafilcon A contact lens randomly assigned to one eye, with delefilcon A contact lens in the fellow eye for contralateral wear. Both products worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week, with spectacles worn over contact lenses if needed to provide acceptable vision.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Delefilcon A contact lens</intervention_name>
    <description>Commercially available silicone hydrogel contact lens</description>
    <arm_group_label>DAILIES TOTAL1</arm_group_label>
    <arm_group_label>TRUEYE</arm_group_label>
    <other_name>DAILIES® TOTAL1®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Narafilcon A contact lens</intervention_name>
    <description>Commercially available silicone hydrogel contact lens</description>
    <arm_group_label>DAILIES TOTAL1</arm_group_label>
    <arm_group_label>TRUEYE</arm_group_label>
    <other_name>1-DAY ACUVUE TRUEYE™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spectacles</intervention_name>
    <description>Incremental prescription worn over contact lenses if needed to provide acceptable vision</description>
    <arm_group_label>DAILIES TOTAL1</arm_group_label>
    <arm_group_label>TRUEYE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sign Informed Consent document;

          -  Higher degree of myopia in both eyes, i.e. habitual contact lens power between -10.00
             diopters (D) and -17.00D;

          -  Best corrected distance visual acuity greater than or equal to 20/30 in each eye
             (measured with either spectacle refraction or habitual contact lenses plus over
             refraction);

          -  Manifest astigmatism less than or equal to -1.00D;

          -  Soft contact lens wear in both eyes at least 5 days per week and at least 8 hours per
             day;

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Pregnant or lactating;

          -  Eye injury or surgery within twelve weeks immediately prior to enrollment;

          -  Any ocular condition that contraindicates contact lens wear;

          -  History of herpetic keratitis;

          -  Any use of systemic or ocular medications for which contact lens wear could be
             contraindicated, including any use of topical ocular medications that would require
             instillation during contact lens wear, except for approved lubricating drops;

          -  Clinical significant dry eye not responding to treatment;

          -  Previous corneal or refractive surgery or irregular cornea;

          -  Requires reading glasses;

          -  Participation in a clinical trial (including contact lens or contact lens care
             product) within the previous 30 days;

          -  Wears habitual lenses in an extended wear modality (routinely sleeps in lenses
             overnight for 1 night per week or more) over the last 3 months prior to enrollment;

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joachim Nick, Dipl. Ing.</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2013</study_first_submitted>
  <study_first_submitted_qc>February 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2014</study_first_posted>
  <results_first_submitted>May 26, 2015</results_first_submitted>
  <results_first_submitted_qc>May 26, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 8, 2015</results_first_posted>
  <last_update_submitted>May 26, 2015</last_update_submitted>
  <last_update_submitted_qc>May 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contact lenses</keyword>
  <keyword>Nearsightedness</keyword>
  <keyword>Corneal curvature</keyword>
  <keyword>K-reading</keyword>
  <keyword>High minus</keyword>
  <keyword>Spectacle refraction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from 2 study centers located in the US and 2 study centers located in Germany.</recruitment_details>
      <pre_assignment_details>Of the 19 enrolled, 4 participants were exited as screen failures prior to randomization. This reporting group includes all randomized participants (15).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>DAILIES TOTAL1/TRUEYE</title>
          <description>Delefilcon A and narafilcon A contact lenses (1 in each eye) worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This analysis group includes all randomized participants.</population>
      <group_list>
        <group group_id="B1">
          <title>DAILIES TOTAL1/TRUEYE</title>
          <description>Delefilcon A and narafilcon A contact lenses (1 in each eye) worn in a daily wear, daily disposable mode approximately 8 hours a day for approximately 1 week.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.2" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Average Central Corneal Curvature From Dispense at Week 1</title>
        <description>Corneal curvature (horizontal and vertical keratometry values on the same eye) was measured using a calibrated keratometer prior to study lens dispense (Day 1) and approximately 15 minutes after study lens removal following 8 hours of wear (Week 1). Minus values in change-from-baseline indicate corneal flattening.</description>
        <time_frame>Dispense (Day 1 of lens wear), Week 1 (Day 8 of lens wear)</time_frame>
        <population>This analysis group includes all randomized participants with data present at visit.</population>
        <group_list>
          <group group_id="O1">
            <title>DAILIES TOTAL1</title>
            <description>Delefilcon A contact lens worn in 1 eye approximately 8 hours a day for 1 week</description>
          </group>
          <group group_id="O2">
            <title>TRUEYE</title>
            <description>Narafilcon A contact lens worn in 1 eye approximately 8 hours a day for 1 week.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Average Central Corneal Curvature From Dispense at Week 1</title>
          <description>Corneal curvature (horizontal and vertical keratometry values on the same eye) was measured using a calibrated keratometer prior to study lens dispense (Day 1) and approximately 15 minutes after study lens removal following 8 hours of wear (Week 1). Minus values in change-from-baseline indicate corneal flattening.</description>
          <population>This analysis group includes all randomized participants with data present at visit.</population>
          <units>diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.44" spread="0.46"/>
                    <measurement group_id="O2" value="-0.11" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Eyes With Change of &gt;1.00 Diopter (D) in Spherical Equivalent of Subjective Refraction From Baseline at Week 1</title>
        <description>Subjective manifest refraction was assessed using a phoropter or trial frame set with the subject’s current prescription at Baseline (Visit 2) after a 2-day washout period and approximately 15 minutes after study lens removal following 8 hours of wear (Week 1). Spectacle over-refraction, if required, was performed. Higher myopia is indicated by larger negative values in manifest refraction.</description>
        <time_frame>Baseline, Week 1 (Day 8 of lens wear)</time_frame>
        <population>This analysis group includes all randomized participants with data present at visit.</population>
        <group_list>
          <group group_id="O1">
            <title>DAILIES TOTAL1</title>
            <description>Delefilcon A contact lens worn in 1 eye approximately 8 hours a day for 1 week.</description>
          </group>
          <group group_id="O2">
            <title>TRUEYE</title>
            <description>Narafilcon A contact lens worn in 1 eye approximately 8 hours a day for 1 week.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Eyes With Change of &gt;1.00 Diopter (D) in Spherical Equivalent of Subjective Refraction From Baseline at Week 1</title>
          <description>Subjective manifest refraction was assessed using a phoropter or trial frame set with the subject’s current prescription at Baseline (Visit 2) after a 2-day washout period and approximately 15 minutes after study lens removal following 8 hours of wear (Week 1). Spectacle over-refraction, if required, was performed. Higher myopia is indicated by larger negative values in manifest refraction.</description>
          <population>This analysis group includes all randomized participants with data present at visit.</population>
          <units>Eyes</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events (AEs) were collected for the duration of the study (March, 2014 – May, 2014). This analysis group includes all participants/eyes exposed to the study products. Trial-fit lenses were not considered study products.</time_frame>
      <desc>An AE was defined as any untoward medical occurrence, unintended disease or injury, or untoward clinical signs in subjects, users, or other persons, whether or not related to the investigational medical device.</desc>
      <group_list>
        <group group_id="E1">
          <title>DAILIES TOTAL1</title>
          <description>Delefilcon A contact lens worn in 1 eye approximately 8 hours a day for 1 week</description>
        </group>
        <group group_id="E2">
          <title>TRUEYE</title>
          <description>Narafilcon A contact lens worn in 1 eye approximately 8 hours a day for 1 week</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (16.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Foreign body sensation in eyes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Metamorphopsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Ocular discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Punctate keratitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Topography corneal abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Myokymia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor reserves the right of prior review of any publication or presentation of information related to the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Lead, Vision Care Development</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>1-888-451-3937</phone>
      <email>alcon.medinfo@alcon.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

